Pulmonx (LUNG) Short term Debt (2021 - 2025)

Pulmonx (LUNG) has reported Short term Debt for 5 consecutive years, with $106000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Short term Debt fell 96.66% year-over-year to $106000.0 in Q4 2025; TTM through Dec 2025 was $106000.0, a 96.66% decrease from a year earlier, with the FY2025 full-year figure at $106000.0, down 96.66% from the prior year.
• Short term Debt was $106000.0 for Q4 2025 at Pulmonx, up from $105000.0 in the prior quarter.
• Over five years, Short term Debt peaked at $7.8 million in Q1 2025 and troughed at $90000.0 in Q4 2022.
• A 5-year average of $1.7 million and a median of $289000.0 in 2021 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt tumbled 98.2% in 2023 and surged 5648.35% in 2024, its largest moves.
• Over 5 years, Short term Debt stood at $91000.0 in 2021, then dropped by 1.1% to $90000.0 in 2022, then surged by 2294.44% to $2.2 million in 2023, then jumped by 47.38% to $3.2 million in 2024, then sank by 96.66% to $106000.0 in 2025.
• The last three Short term Debt figures came in at $106000.0 (Q4 2025), $105000.0 (Q3 2025), and $104000.0 (Q2 2025), per Business Quant data.